2-CHLORO 2,6-DIMETHYL ACETANILIDE

Product Information : Product Name : 2-CHLORO 2,6-DIMETHYL ACETANILIDE Powder Grade : IH Manufacturer : Cerata Pharmaceuticals LLP Packaging : HDPE Drum Shelf Life : 5 years API Form : Powder Country Of Origin : India COA : Available MSDS : Available Availability : Ready Stock About the Company GST Registration Date: 2022 Legal Status of Firm: Partnership Number of Employees: 26 To 50 People Annual Turnover: 1.5 - 5 Cr company-description: Established in the year of 2022, We "Cerata Pharmaceuticals LLP." are Manufacturer and Exporter of an Sumatriptan Succinate Powder, Tacrolimus API Powder, Rosuvastatin Calcium API Powder, Bupivacaine Base Powder, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. For our accomplishment story, we are grateful to our Mr. Pratik Kansara, whose continual backing and direction have been useful to us for attaining exponential development in the current market. Cerata Pharmaceuticals LLP is a fully integrated company involved in the complete lifecycle of Active Pharmaceutical Ingredients (API) including the development, production, and sales of Active Pharmaceutical Ingredients (API), High Potency API and API intermediates. Cerata Pharmaceuticals has become the go-to choice for pharmaceutical companies looking for high-quality APIs for their formulations. We've achieved this reputation by maintaining cutting-edge facilities and holding ourselves to strict international quality standards. Our commitment is a testament to Cerata's importance in India's pharmaceutical landscape, contributing to the industry's growth and development. Cerata Pharmaceuticals LLP has been serving the pharmaceutical industry, operating multiple state-of-the-art manufacturing plants spread across India dedicated to the production of APIs. Our APIs have gained a well-deserved reputation for their exceptional quality and cost-effectiveness. This distinction makes them the preferred choice for pharmaceutical companies seeking to manufacture quality products while maintaining cost efficiency and competitiveness. Our Key Priorities We are an Indian pharmaceutical company which believes that everyone has a right to affordable quality medicines. We have a clear goal of giving patients access to quality and affordable products. For this we are aiming to alter the healthcare paradigm. We are now at strong position to research and develop quality API by optimising cost-effective paths of pharmaceutical chemistry - which is our first step to achieve our goals of patient centricity through optimised chemistry.